Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07200466Not ApplicableRecruiting

Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

Role: collaborator

NCT07283484Not ApplicableRecruiting

Early Versus Delayed Trial Without Catheter in Men With Acute Urinary Retention.

Role: collaborator

NCT07252245Not ApplicableNot Yet Recruiting

Pre Hospital Triage of Patients at Intermediate and High Risk for ACS

Role: collaborator

NCT05899114Not ApplicableActive Not Recruiting

Less Is More: Optimized Pharmacotherapy With Improved coNtinuity of CarE in hospitaLized oLder peOple

Role: collaborator

NCT06844006Not ApplicableRecruiting

Investigating the Impact of Nudging Cardiologists to Prescribe Guideline-directed Medical Therapy in Heart Failure Patients

Role: collaborator

All 5 trials loaded